Citadel Advisors’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348K | Sell |
59,230
-212,042
| -78% | -$1.25M | ﹤0.01% | 4447 |
|
|
2025
Q1 | $2.28M | Buy |
271,272
+9,502
| +4% | +$79.7K | ﹤0.01% | 2477 |
|
|
2024
Q4 | $1.95M | Buy |
261,770
+191,230
| +271% | +$1.42M | ﹤0.01% | 2633 |
|
|
2024
Q3 | $409K | Sell |
70,540
-421,334
| -86% | -$2.44M | ﹤0.01% | 3993 |
|
|
2024
Q2 | $3.27M | Buy |
491,874
+427,755
| +667% | +$2.84M | ﹤0.01% | 2005 |
|
|
2024
Q1 | $837K | Sell |
64,119
-69,175
| -52% | -$903K | ﹤0.01% | 3375 |
|
|
2023
Q4 | $1.7M | Buy |
133,294
+7,337
| +6% | +$93.5K | ﹤0.01% | 2542 |
|
|
2023
Q3 | $1.65M | Buy |
125,957
+62,571
| +99% | +$820K | ﹤0.01% | 2560 |
|
|
2023
Q2 | $1.62M | Sell |
63,386
-498,726
| -89% | -$12.8M | ﹤0.01% | 2590 |
|
|
2023
Q1 | $14.2M | Buy |
562,112
+205,474
| +58% | +$5.18M | ﹤0.01% | 1066 |
|
|
2022
Q4 | $8.2M | Buy |
356,638
+203,216
| +132% | +$4.67M | ﹤0.01% | 1427 |
|
|
2022
Q3 | $3.39M | Buy |
153,422
+89,752
| +141% | +$1.98M | ﹤0.01% | 2225 |
|
|
2022
Q2 | $913K | Sell |
63,670
-41,646
| -40% | -$597K | ﹤0.01% | 3501 |
|
|
2022
Q1 | $1.99M | Buy |
105,316
+35,117
| +50% | +$664K | ﹤0.01% | 3012 |
|
|
2021
Q4 | $1.31M | Sell |
70,199
-58,894
| -46% | -$1.1M | ﹤0.01% | 3488 |
|
|
2021
Q3 | $3.47M | Buy |
129,093
+25,852
| +25% | +$695K | ﹤0.01% | 2402 |
|
|
2021
Q2 | $3.23M | Buy |
+103,241
| New | +$3.23M | ﹤0.01% | 2663 |
|